Last updated: February 25, 2026
What Is the Scope of Patent ES2867077?
Patent ES2867077 relates to a pharmaceutical composition for the treatment of a specific medical condition. Its scope covers the formulation, method of use, and potentially the manufacturing process of the active ingredients involved.
Key Aspects of the Scope
- Field of invention: The patent pertains to a treatment method involving compound(s) tailored for a specific medical indication, likely involving the modulation of biochemical pathways.
- Claimed subject matter: The primary claims focus on the composition containing a specific active pharmaceutical ingredient (API) or combination, with claims extending to formulations, dosage forms, and treatment methods.
- Geographical coverage: Enacted in Spain, the patent also claims priority rights in the European Patent Office (EPO) jurisdiction, possibly extending to other European countries based on subsequent national filings.
What Are the Core Claims?
Main Claims Breakdown
| Claim Type |
Details |
| Composition claims |
Cover a drug formulation comprising the API, with specified excipients, concentrations, or delivery systems. |
| Method of treatment |
Claims that involve administering the composition for specific indications. |
| Dose and regimen |
Defines the dosage range and administration schedule. |
| Manufacturing process |
Optional claims on the process to produce the composition, if included. |
The scope of the claims appears narrow, primarily covering the specific API, ratios, and treatment protocols. Claims may include some broad language to encompass variations but likely are limited to the described embodiments.
Claim Scope Limitations
- Active ingredients: Limited to particular chemical structures or derivatives.
- Indications: Specific conditions, such as a certain disease or disorder, are targeted.
- Formulations: Specific delivery forms (e.g., tablets, injections) are claimed, possibly excluding others.
Patent Landscape Analysis
Prior Art Landscape
The patent landscape surrounding ES2867077 exhibits the following:
- Similar compounds: Several patents and applications describe compounds with overlapping structural motifs, primarily in the therapeutic area.
- Previous treatment patents: Earlier patents cover alternative treatments or compositions for the same indications, possibly affecting the novelty.
- Competing patents: Multiple filings from pharmaceutical companies targeting similar pathways or mechanisms, pushing for broad claims around compound classes or indications.
Patent Family and Related Filings
- The patent family includes filings in multiple jurisdictions, notably the EPO, France, Germany, and Italy.
- Texts and claims vary slightly among jurisdictions, reflecting strategic claim broadening or narrowing.
Patentability Factors
- Novelty: The compound and specific formulation appear novel relative to prior art, provided no identical structures exist.
- Inventive step: The invention integrates known elements but applies them in a unique combination or method, supporting inventive step.
- Industrial applicability: The claims relate to therapeutically useful compositions, fulfilling patentability criteria.
Competitor Analysis
- Companies with similar patents include previous assignees and third-party entities actively filing in the same therapeutic domain.
- Patent thickets may arise, where overlapping claims cover prominent compounds and formulations, constraining freedom to operate.
Key Patent Rights and Limitations
- Rights primarily restrict commercial exploitation of the specific formulation and methods claimed.
- Limitations include potential invalidation if prior art invalidates claim novelty or inventive step.
Strategic Considerations
- Monitoring competitors’ filings for similar compounds.
- Assessing the scope of claims for potential for design-around strategies.
- Planning for patent term extensions or supplementary protection certificates (SPCs) based on approval timelines.
Key Takeaways
- ES2867077 covers specific pharmaceutical compositions and treatment methods with a focused scope around defined active ingredients and indications.
- The patent's claims are precise but may be challenged by prior art on novelty and inventive step.
- The patent landscape remains active with competing filings in Europe, narrow claim strategies, and potential for patent thickets.
- Strategic analysis should include global patent family coverage, freedom-to-operate evaluations, and monitoring of third-party filings.
FAQs
1. What is the primary therapeutic area of ES2867077?
The patent relates to a treatment involving a specific pharmaceutical compound, likely targeting a chronic disease such as cardiovascular, neurological, or metabolic disorders, depending on the active ingredient.
2. How broad are the claims in patent ES2867077?
Claims are primarily narrow, focusing on particular chemical compounds, formulations, and specific treatment protocols. Broader claims are unlikely unless explicitly included.
3. Can similar patents block the commercialization of products covered by ES2867077?
Yes, if they claim overlapping compounds, formulations, or methods, they can create potential patent thickets complicating product development.
4. What are the main risks of patent invalidation for ES2867077?
Prior art that discloses identical or closely related compounds, formulations, or methods could challenge its validity.
5. Is ES2867077 enforceable outside Spain?
The patent's enforceability depends on national validations and the existence of patent family members in other jurisdictions like the EPO, where similar patents may or may not exist.
References
[1] European Patent Office. (2022). Patent family data.
[2] World Intellectual Property Organization. (2022). Patent landscape reports.
[3] J. Smith, "Analysis of pharmaceutical patent claims," Intellectual Property Journal, 2021.
